These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 23610963
41. Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancer. Mullen P, McPhillips F, MacLeod K, Monia B, Smyth JF, Langdon SP. Clin Cancer Res; 2004 Mar 15; 10(6):2100-8. PubMed ID: 15041731 [Abstract] [Full Text] [Related]
42. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60). Kachalaki S, Baradaran B, Majidi J, Yousefi M, Shanehbandi D, Mohammadinejad S, Mansoori B. Biomed Pharmacother; 2015 Oct 15; 75():100-4. PubMed ID: 26463638 [Abstract] [Full Text] [Related]
43. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice. Kobzdej M, Matuszyk J, Strzadala L. Leuk Res; 2000 Jan 15; 24(1):33-8. PubMed ID: 10634643 [Abstract] [Full Text] [Related]
47. Antisense therapy in oncology: new hope for an old idea? Tamm I, Dörken B, Hartmann G. Lancet; 2001 Aug 11; 358(9280):489-97. PubMed ID: 11513935 [Abstract] [Full Text] [Related]
48. Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages. Olie RA, Hafner C, Küttel R, Sigrist B, Willers J, Dummer R, Hall J, Stahel RA, Zangemeister-Wittke U. J Invest Dermatol; 2002 Mar 11; 118(3):505-12. PubMed ID: 11874491 [Abstract] [Full Text] [Related]
49. No compensation in CD44 stem cell marker following BCL-2 suppression by antisense oligonucleotides. Rubenstein M, Hollowell CM, Guinan P. In Vivo; 2013 Mar 11; 27(2):251-6. PubMed ID: 23422486 [Abstract] [Full Text] [Related]
50. Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A. Ma X, Duan H, Liu J, Mo Q, Sun C, Ma D, Wang J. Oncol Rep; 2015 Feb 11; 33(2):893-8. PubMed ID: 25420545 [Abstract] [Full Text] [Related]
51. Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma. Julien T, Frankel B, Longo S, Kyle M, Gibson S, Shillitoe E, Ryken T. Surg Neurol; 2000 Apr 11; 53(4):360-8; discussion 368-9. PubMed ID: 10825522 [Abstract] [Full Text] [Related]
56. Effects of tetracycline-controlled antisense bcl-2 expression on the growth and apoptosis of human neuroblastoma cell line SK-N-MC. Guan J, Chen J, Zhao H. Zhonghua Bing Li Xue Za Zhi; 2002 Apr 11; 31(2):135-9. PubMed ID: 12419161 [Abstract] [Full Text] [Related]
57. Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells. Kaewpiboon C, Srisuttee R, Malilas W, Moon J, Oh S, Jeong HG, Johnston RN, Assavalapsakul W, Chung YH. Mol Med Rep; 2015 Mar 11; 11(3):2315-21. PubMed ID: 25395162 [Abstract] [Full Text] [Related]
58. Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides. Funato T, Kozawa K, Fujimaki S, Kaku M. Anticancer Drugs; 2001 Apr 11; 12(4):325-9. PubMed ID: 11335788 [Abstract] [Full Text] [Related]